This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3kcf
From Proteopedia
| Line 1: | Line 1: | ||
{{Seed}} | {{Seed}} | ||
| - | [[Image:3kcf. | + | [[Image:3kcf.png|left|200px]] |
<!-- | <!-- | ||
| Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
| - | 3KCF is a 5 chains structure | + | 3KCF is a 5 chains structure with sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3KCF OCA]. |
==Reference== | ==Reference== | ||
| Line 49: | Line 49: | ||
[[Category: Transmembrane]] | [[Category: Transmembrane]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 25 09:40:42 2010'' |
Revision as of 07:40, 25 February 2010
Crystal structure of TGFbRI complexed with a pyrazolone inhibitor
Template:ABSTRACT PUBMED 19914068
About this Structure
3KCF is a 5 chains structure with sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Guckian K, Carter MB, Lin EY, Choi M, Sun L, Boriack-Sjodin PA, Chuaqui C, Lane B, Cheung K, Ling L, Lee WC. Pyrazolone based TGFbetaR1 kinase inhibitors. Bioorg Med Chem Lett. 2010 Jan 1;20(1):326-9. Epub 2009 Oct 29. PMID:19914068 doi:10.1016/j.bmcl.2009.10.108
Page seeded by OCA on Thu Feb 25 09:40:42 2010
Categories: Homo sapiens | Receptor protein serine/threonine kinase | Boriack-Sjodin, P A. | Aortic aneurysm | Atp-binding | Craniosynostosis | Disease mutation | Disulfide bond | Glycoprotein | Kinase | Magnesium | Manganese | Membrane | Metal-binding | Nucleotide-binding | Phosphoprotein | Polymorphism | Protein-inhibitor complex | Receptor | Serine/threonine-protein kinase | Structure-based drug design | Tgfbetari | Transferase | Transmembrane
